PIPERACILLIN AND TAZOBACTAM
Generic: PIPERACILLIN AND TAZOBACTAM
Fresenius Kabi USAManufacturer
INTRAVENOUSRoute
PIPERACILLIN SODIUMActive Substance
2018-05-18Original Approval
PIPERACILLIN AND TAZOBACTAM is FDA application ANDA203719, sponsored by FRESENIUS KABI. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class I2018-07-02
Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured for: AuromedPresence of Particulate Matter: identified as glass and silicone material
Class I2018-05-01
Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx OnlyPresence of Particulate Matter: confirmed customer report for presence of visible particulate matter
Top Reported Reactions
1
DRUG INEFFECTIVE
2,941 reports
2
OFF LABEL USE
2,609 reports
3
ACUTE KIDNEY INJURY
2,014 reports
4
PYREXIA
1,735 reports
5
CONDITION AGGRAVATED
1,097 reports
6
DIARRHOEA
1,084 reports
7
THROMBOCYTOPENIA
1,029 reports
8
PNEUMONIA
987 reports
9
NEUTROPENIA
951 reports
10
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
916 reports